About
Antibodies for Autoimmune Diseases
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySan Diego & Southern California
Team (13)
Aaron Royston
Aaron Royston, MD, MBA
Candid Therapeutics
team_member
Angie You
Angie You, PhD
Candid Therapeutics
team_member
Arvind Kush
Arvind Kush
Candid Therapeutics
team_member
Bernie Huyghe
Bernie Huyghe, PhD
Candid Therapeutics
team_member
Dan Puckett
Dan Puckett
Candid Therapeutics
team_member
David Luo
David Luo
Candid Therapeutics
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
138
By Phase
PHASE1: 3
By Status
NOT_YET_RECRUITING: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07215650Lead Sponsor
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
PHASE1Not yet recruiting
44 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2028
NCT07215663Lead Sponsor
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
PHASE1Not yet recruiting
47 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2028
NCT07052032Lead Sponsor
An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis
PHASE1Recruiting
47 participants
Started: Jun 16, 2025 · Completed: Jun 1, 2027
Funding History (1)
D
Sep 13, 2024
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...